BrightOwl Loader Loading

Scientist I, Genetic and Genomic Technology Cambridge United States,  


Posted on : 07 May 2017

Project Description

External Posting TitleScientist I, Genetic and Genomic Technology Job DescriptionComputational Biology and Genomics (CBG) is a center of excellence platform line in the Research and Early Development organization at Biogen. The group is responsible for providing genetics and genomics expertise to the R and D organization and specifically applies genetic and genomic discoveries to support Biogen s drug discovery research clinical development programs. This position will report into the NGS and Genetic Technologies Hub in the CBG organization which provides laboratory support and delivers data to support human disease genetics research projects. We are looking for a PhD level scientist to focus on studying genetics of gene regulation in multiple diseases of interest, and help evaluate, develop and implement novel NGS, RNA and/or DNA technologies to support such studies and other CBG strategic imperatives. The successful candidate will be expected to work closely with Biogen discovery, clinical, and computational scientists to deliver high content genetic and genomic data to impact drug discovery and development activities at Biogen. This individual will employ creative molecular solutions to advance our understanding of the molecular basis of the complex diseases we seek to treat, supporting the discovery of novel potential drug targets, biomarkers, and provide information on drug mechanism of action. As a subject matter expert on specific genomic technologies this role will interface with project teams to provide guidance on application of technologies, experimental design and data interpretation and keep Biogen at the cutting edge of genomic sciences. Responsibilities• Develop a program of research in the area of the genetics of gene regulation that will support Biogen s drug discovery efforts in neurology and rare genetic disease. • Identify, evaluate and develop novel genomic technologies to advance drug discovery and development activities• Partner with TA scientists in Discovery Research and Clinical Development team leaders to identify key questions and priorities that novel genetic and genomic technologies can impact• Deliver high content molecular data for key research projects in CBG • Identify opportunities for external collaborations that supplement internal CBG resources and ensure genetic and genomic biomarker research is at the cutting edge*LI-RD2 LocationCambridge, MA, US Job CategoryResearch Requisition Number30157BR QualificationsPhD in genetics, genomics or a related discipline. Post-doctoral experience is not essential. • Keen interest in the application of new genetic and genomic technology and deep understanding of human genetics. • Expertise in NGS technologies and hands on experience developing creative solutions to address biological questions. • Experience of the evaluation of different genomic technologies. • Strong collaboration, organizational and communication skills and an ability to work well in a team setting are required. • The candidate should have be able to work independently have a strong ability to learn and adapt to work on new tasks and projects that he/she may not have worked on previously. EducationPh.D in Genetics, Genomics or a related discipline About BiogenCorporate Overview Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis (MS), has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer s disease, Parkinson s disease and amyotrophic lateral sclerosis (ALS). Biogen also manufactures and commercializes biosimilars of advanced biologics. Our global organization of nearly 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients with few or no treatment options. Biogen was founded in 1978 and today serves patients in nearly 70 countries. A Fortune 500 company, Biogen in 2016 had revenues of $11.4 billion Global headquarters in Cambridge, MA, and international headquarters in Zug, Switzerland Our Science We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry. To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments. For nearly two decades Biogen has led in the research and development of new therapies to treat MS, including the most prescribed oral treatment in the world. Now our research is driving revolutionary new MS treatments with the goal of reversing or even repairing damage caused by the disease.We are now applying our neurological expertise to solve some of most challenging and complex diseases of the brain, including Alzheimer s disease, Parkinson s disease, and ALS.As we uncover new insights into human biology, Biogen is employing cutting-edge technologies to discover potential treatments for rare and genetic disorders. Biogen is revolutionizing biologics manufacturing, developing the industry s most advanced plants and processes. This expertise is used to produce both original innovative therapies and biosimilars that expand patient access to lower-cost medicines. Our Corporate Citizenship The same intellectual discipline and passion that drives our science is reflected in our corporate citizenship, environmental sustainability, and commitment to diversity and inclusion. As a company, we are focused on improving science education and limiting the impact of our company on the environment. In 2015, we became a carbon neutral company and ranked first place on Newsweek s 2015 Green Rankings, and we are an industry leader on the Dow Jones Sustainability World Index. Biogen was named to Science s list of Top Employers of 2015 and in 2017 received a perfect score of 100 for the fourth consecutive year on the Human Rights Campaign (HRC) Corporate Equality Index, which also named Biogen as one of its Best Places to Work. All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States. Please be advised that all legitimate correspondence from a Biogen employee will come from "@biogen.com" email accounts. Nearest Major Market: Cambridge Nearest Secondary Market: Boston Job Segment: Scientific, Genetics, Biotech, Scientist, Engineering, Science, Research

Locations

Cambridge MA US

Find a Job Find Candidates

Most Recent Searches

Most Famous Searches

You might also like